Brief: Sprint Bioscience: inhibition of autophagy with SB02024 activates immune system in tumor
Oct 27 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* HAS SHOWN THAT INHIBITION OF AUTOPHAGY WITH SB02024
ACTIVATES IMMUNE SYSTEM IN TUMOR
Source text for Eikon: ID:nWkr5sX18R
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln